Nicotine: from molecular mechanisms to behaviour
- PMID: 15661626
- DOI: 10.1016/j.coph.2004.12.002
Nicotine: from molecular mechanisms to behaviour
Abstract
The addictive potential of nicotine is clearly recognized by the tenacity of tobacco smoking for most users, and has prompted extensive psychopharmacological studies in animals. In parallel, the interaction of nicotine with the many subtypes of its eponymous receptor has been the focus of molecular and cellular investigations. More recently, a convergence of these approaches has been stimulated by the generation of transgenic animals, which facilitates analysis of the impact of molecular changes on behaviour. Nicotine, like other addictive drugs including psychomotor stimulants, promotes dopamine release in the nucleus accumbens. This transmitter system has been a major focus of both neurochemical and behavioural investigations, although recently the pre-eminence of this system in nicotine dependence has been challenged. Complexities in the brain circuitry (including the subdivisions of the nucleus accumbens) and differences between behavioural models help to rationalise the current controversy.
Similar articles
-
Nicotine activates and desensitizes midbrain dopamine neurons.Nature. 1997 Nov 27;390(6658):401-4. doi: 10.1038/37120. Nature. 1997. PMID: 9389479
-
Nicotinic receptors and stages of nicotine dependence.J Psychopharmacol. 2010 Jun;24(6):793-808. doi: 10.1177/0269881108100256. Epub 2009 Feb 27. J Psychopharmacol. 2010. PMID: 19251827 Review.
-
The neuronal pathways mediating the behavioral and addictive properties of nicotine.Handb Exp Pharmacol. 2009;(192):209-33. doi: 10.1007/978-3-540-69248-5_8. Handb Exp Pharmacol. 2009. PMID: 19184651 Review.
-
Molecular and cellular mechanisms of action of nicotine in the CNS.Handb Exp Pharmacol. 2009;(192):173-207. doi: 10.1007/978-3-540-69248-5_7. Handb Exp Pharmacol. 2009. PMID: 19184650 Review.
-
Nicotine addiction: insights from recent animal studies.Psychopharmacology (Berl). 2002 Jul;162(2):102-18. doi: 10.1007/s00213-002-1096-0. Epub 2002 May 15. Psychopharmacology (Berl). 2002. PMID: 12110988 Review.
Cited by
-
The Role of CaMKII and ERK Signaling in Addiction.Int J Mol Sci. 2021 Mar 20;22(6):3189. doi: 10.3390/ijms22063189. Int J Mol Sci. 2021. PMID: 33804804 Free PMC article. Review.
-
Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement.J Psychopharmacol. 2021 Oct;35(10):1204-1215. doi: 10.1177/0269881121991570. Epub 2021 Mar 10. J Psychopharmacol. 2021. PMID: 33691518 Free PMC article.
-
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.Patient Prefer Adherence. 2010 Oct 5;4:355-62. doi: 10.2147/ppa.s10620. Patient Prefer Adherence. 2010. PMID: 21049087 Free PMC article.
-
Nicotine and Parkinson's disease: implications for therapy.Mov Disord. 2008 Sep 15;23(12):1641-52. doi: 10.1002/mds.21900. Mov Disord. 2008. PMID: 18683238 Free PMC article. Review.
-
Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior.Psychopharmacology (Berl). 2009 Mar;203(1):99-108. doi: 10.1007/s00213-008-1375-5. Epub 2008 Nov 6. Psychopharmacology (Berl). 2009. PMID: 18987848
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources